Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Ozempic (semaglutide) and Mounjaro (tirzepatide) are both FDA-approved GLP-1 receptor agonists used to treat type 2 diabetes
It is a powerful antioxidant that plays a protective role in the body as well as boosting your immune system, balancing blood sugar, improving hair and skin conditions
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Effective weight loss They help patients lose more weight compared to lifestyle changes alone
How Lupus Can Impact Appearance As most of us know, our bodies and faces change as we age
